Edwards Lifesciences Corp
NYSE:EW
Edwards Lifesciences Corp
NYSE:EW
Price:
86.43 USD
-1.8%
Market Closed
Updated:
Apr 29, 2024
Edwards Lifesciences Corp
Cash from Financing Activities
|
Edwards Lifesciences Corp
Cash from Financing Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Cash from Financing Activities
-$711m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-68%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.6B
|
CAGR 3-Years
-425%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Edwards Lifesciences Corp's Cash from Financing Activities?
Cash from Financing Activities
-711m
USD
-711m
USD
Based on the financial report for Dec 31, 2023, Edwards Lifesciences Corp's Cash from Financing Activities amounts to -711m USD.
What is Edwards Lifesciences Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
8%
8%
Over the last year, the Cash from Financing Activities growth was 55%. The average annual Cash from Financing Activities growth rates for Edwards Lifesciences Corp have been -13% over the past three years , 8% over the past five years .
You don't have any saved screeners yet
